Divestment of Carmeda (SE) to HealthCap and Investor Growth Capital (SE) by Norsk Hydro (NO) — SEK 200 million

Carnegie acted as financial adviser to Norsk Hydro, Norway’s largest industrial group with core business areas Oil&Gas, Light Metals and Fertilizer, in the sale of Carmeda to a HealthCap and Investor Growth Capital led consortium. In addition to the cash proceeds of SEK 200 million, the sellers will receive royalties on a certain share of Carmeda’s future sales revenues. Carmeda develops, produces and markets biologically active biocompatible surfaces for disposable medical devices and implants, mainly in the fields of cardiology, cardiac surgery and vascular surgery. August, 2003.